Gut bacteria diversity, digestive health, probiotics, prebiotics, and the gut-brain axis
361 articoli
New research shows integrated HBV DNA — not active viral replication — is the dominant source of surface antigen in HBeAg-negative chronic hepatitis B.
A comprehensive review reveals how SCFAs, bile acids, and tryptophan metabolites reshape the tumor immune microenvironment in GI cancers.
A comprehensive 2025 review maps how bacterial, fungal, and viral dysbiosis fuels colorectal cancer — and points to new diagnostic and therapeutic targets.
A comprehensive review maps the full immunopathology of IBD, linking cytokine cascades, barrier dysfunction, and emerging biomarkers to diagnosis and treatment.
A landmark infant nasal microbiome atlas reveals that hypertonic saline inhalation accelerates dangerous pathogen growth and antibiotic tolerance.
A microbiome metabolite depleted by antipsychotics protects synapses and cognition — and supplementing it may reverse the damage.
Aged mouse colons get stuck in a fetal-like repair mode that makes them hypersensitive to immune attack, derailing gut healing after injury.
Scientists argue that static microbiome health metrics miss the point — what matters is how flexibly your gut adapts over time.
A landmark review maps the vaginal microbiome's role in infections and reproductive health, charting a path to precision probiotic therapies.
A large cohort study finds HMOs have age-dependent, structure-specific effects on infant gut bacteria that persist to 13 months.
A modular bioelectronic sensing system uses engineered bacterial co-cultures to detect metals, molecules, and peptides across diverse real-world environments.
Bacteriophages transferred during FMT may drive horizontal gene transfer, altering microbial function and antibiotic resistance in ways science has largely ignored.
